AI assistant
Sending…
Longeveron Inc. — Director's Dealing 2022
May 20, 2022
35052_dirs_2022-05-19_595c1933-8c12-41a2-a173-be39aaa1b2bf.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Longeveron Inc. (LGVN)
CIK: 0001721484
Period of Report: 2022-05-17
Reporting Person: DS MED LLC (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-05-17 | Common Stock | J | 7024208 | — | Disposed | 0 | Direct |
Footnotes
F1: Shares consist of Class B common stock (the "Class B Common Stock"), which is not registered under the Securities Exchange Act of 1934, as amended. Holders of Class B Common Stock have identical rights to holders of common stock, except that holders of Class B Common Stock are entitled to 5 votes for each share held of record. Each share of Class B Common Stock is convertible at any time, at the option of the holder, into one share of common stock.
F2: Shares distributed on a pro rated basis to members of DS Med, LLC, for no consideration.
More from Longeveron Inc.
Board/Management Information
2026
Jun 5
Annual Report
2026
May 20
Proxy Solicitation & Information Statement
2026
May 20
Proxy Solicitation & Information Statement
2026
May 20
Interim / Quarterly Report
2026
May 13
Capital/Financing Update
2026
Apr 17
Board/Management Information
2026
Apr 10
Capital/Financing Update
2026
Apr 10
Delisting Announcement
2026
Mar 25
Regulatory Filings
2026
Mar 25